2024-06-24T12:30:23-07:00 2023-12-31 263053898 Acker & Company 1614 Grande Blvd Tyler TX 75703 990 2023-01-01 811231641 CURE GLAUCOMA FOUNDATION CURE 2147659716 10740 N Central Expressway 300 Dallas TX 75231 Mike Kettles Executive Director 2024-06-24 true Mike Kettles 999009999 true ACKER COMPANY P01234529 9035924584 2 AAL1 IAL1 FAL1 2023 2023-04-26 12:10:37Z Mike Kettles 10740 N Central Expressway 300 Dallas TX 75231 484375 false X www.cureglaucoma.org X 2014 TX The mission of Cure Glaucoma is to improve glaucoma by funding transformational research, disseminating knowledge and expanding treatment availability through global outreach efforts. 11 10 1 20 0 795084 483684 0 -1075 691 0 794009 484375 57000 38050 0 78058 78895 0 41188 749122 426373 884180 543318 -90171 -58943 184928 132060 61 62 184867 131998 The mission of Cure Glaucoma is to improve glaucoma by funding transformational research, disseminating knowledge and expanding treatment availability through global outreach efforts. false false 482946 38050 CGFs mission is to improve quality care for all people, fund transformational research and disseminate knowledge through global outreach efforts. 482946 true true false false false false false false false false true false false false true false false false false false false false false false false false false true false false false false false false false false false false true false false false false false false false false true 1 0 true 1 true false false false false false false false 0 false false false false false false false X 11 10 true false false false false false false true true false false true true true true true true true true false X X Mike Kettles 2147659716 10740 N Central Exprwy Ste 300 Dallas TX 75231 Mike Kettles Exec Dir/Treas 40.00 0.00 X X 78895 0 0 W Stephen Love President 1.00 0.00 X X 0 0 0 Helen L Kornmann MD PhD Secretary 1.00 0.00 X X 0 0 0 Davinder S Grover MD MPH Director 1.00 0.00 X 0 0 0 Joseph K Haggerty Director 1.00 0.00 X 0 0 0 Bradley F Jost MD Director 1.00 0.00 X 0 0 0 Ronald L Fellman MD Director 1.00 0.00 X 0 0 0 Joan Taylor MD Director 1.00 0.00 X 0 0 0 Orlando Carvalho Director 1.00 0.00 X 0 0 0 78895 0 false false false 0 483684 329273 483684 0 691 691 0 0 0 0 0 0 0 0 484375 691 37050 37050 1000 1000 0 0 78895 59211 7846 11838 0 0 0 0 0 0 0 2700 2700 0 0 0 22601 14215 4205 4181 24460 2961 144 21355 0 6410 108 2488 3814 0 0 34361 34361 0 19 19 0 0 747 747 0 Medical Supplies 227323 227323 Medical staff 101950 101950 Prof. Fees-Medical Supplies 3503 3503 ADMINISTRATIVE COSTS 1228 308 920 1071 956 115 543318 482946 19184 41188 137748 79236 42623 48381 0 0 0 0 0 0 307 940 8168 4665 4250 3503 0 0 0 0 0 184928 132060 61 61 1 61 62 X 184867 131998 184867 131998 184928 132060 -58943 6074 X true X false false false X 1095855 229475 219177 795084 483684 2823275 0 0 0 0 1095855 229475 219177 795084 483684 2823275 0 0 2823275 -1075 691 -384 0 -1075 691 -384 0 0 1095855 229475 219177 794009 484375 2822891 1.00000 1.00000 0.00000 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 7470 3967 3503 698 698 3503 Rounding 1 1 484375 484375 484375 543318 543318 543318 false CATALYST FOR A CURE INITIATIV 251 Post Street Suite 600 SAN FRANCISCO CA 94108 25000 0 RESEARCH CENTER FOR VISION HEALTH GLAU 5442 La Sierra Drive DALLAS TX 75231 7000 0 RESEARCH 0 2 9 227323 MEDICAL STAFF 28 101950 false false false Form 990, Part VI, Section B, Line 11b LINE 11B EXPLANATION - A COPY OF THE FORM 990 WAS PROVIDED TO THE EXECUTIVE DIRECTOR PRIOR TO FILING FOR HIS AND/OR THE BOARD'S REVIEW. UPON APPROVAL THE FORM WILL BE FILED. Form 990, Part VI, Section C, Line 18 Other information available upon request. Form 990, Part VI, Section C, Line 19 Other information available upon request. Form 990, Part III, Line 4a Form 990, Part III, Line 4aProgram Service Accomplishments In 2023 the organization operated the following programs. Research - Several unique research initiatives and partnerships are underway or in development:American Glaucoma Society MAPS Grant 2023 marks the 9th year CGF has funded the AGS MAPS Program. This program supports early career glaucoma specialists and scientists by providing tools and resources to further their careers as potential leaders in the science, research and the specialty of glaucoma care.Catalyst for the Cure (CFC) Vision Restoration Initiative - 2023 marks the 4th year CGF has funded a grant to this important program, the goals of CFC are: 1.To develop a strategy for optic nerve cell transplantation2.To develop neuroprotective therapies for glaucoma. In the past year, there has been significant progress on both fronts.Global Outreach - CGF sponsors Medical Mission Trips to provide care for patients in underserved countries:Cure Glaucoma Foundations Train the Trainer, glaucoma drainage device (GDD) implant, Mission Outreach Program - Many glaucoma patients in countries in Africa are greatly underserved. This program is designed to teach qualified ophthalmologists in those countries how to implant the drain and, within 18 months, they will in turn train another physician in their resident country how to do the same. By this process CGF, in partnership with New World Medical, will greatly expand access to effective glaucoma therapy for many people. Our partners who have made this program possible are: New World Medical, the Eye Foundation Hospital, Lagos, Nigeria, the City Eye Hospital, Nairobi, Kenya, the American Academy of Ophthalmology and Cure Glaucoma Foundation and its supportive donors.In 2023, Cure Glaucoma Sponsored the following mission trips:Nigeria Glaucoma Drainage Device Training Class, March 2023In March 2023, Dr. Ogunro and her team from the Eye Foundation Hospital in Nigeria, completed their first in-Country GDD training program for (5) Nigerian physicians. This is in keeping with the Train the Trainer program goals of a self-expanding program where recipients of previous GDD training efforts become the next generation of trainers.We would like to congratulate Dr. Ogunro and her team on this great accomplishment! To support Dr. Ogunro CGF provided medical supplies thanks to the generosity of our medical supply partners. The synergy of partnerships between CGF, skilled physicians like Dr. Ogunro and our medical supply partners results in training of ophthalmologists in advanced glaucoma surgeries all over the world who can better care for their patients.Congratulations to the following physicians who are registered as qualified to participate in the GDD program:Dr Adanma Chinyele Ezenwa - (Nnamdi Azikiwe University Teaching Hospital Nnewi)Dr Genevieve Onochie-Olubobokun - (St Edmund's Eye Clinic and Hospital Lagos)Dr Aisha Kalmbe - (Asokoro District Hospital Abuja)Dr Abdullahi Sadiq Mohammed - (National Eye Centre Kaduna)Dr Adaora Okudo - (Asokoro District Hospital Abuja)A special thanks to New World Medical whose ongoing support and commitment to this important program make it possible to achieve these important goals.Bali, Indonesia 15-17 March 2023In March, the Cure Glaucoma Foundation, in collaboration with the Indonesian Glaucoma Society and the Udayana University/Mangusada Hospital, organized a 3-day global outreach program in Bali, Indonesia. On site, my colleagues Lola Idowu, MD, and Ramya Swamy, MD, and I (Dr. Tosin Smith) executed the MIGS Didactic Course and Wet Lab Conference, during which 36 Indonesian surgeons received training in various glaucoma procedures, with a focus on MIGS. Attendees participated in live and virtual lectures delivered by 12 experts in glaucoma. They also engaged in live surgical training and wet lab sessions, resulting in a total of 25 surgeries performed during the event. For me, the joy of delivering this program stems from witnessing its profound impact on physician education and patient care, both within Indonesia and across the globe. The programs impact extends beyond the immediate patient care provided; it also involves bringing local surgeons up to date with the latest glaucoma procedures and offering ongoing support as they become proficient in newer techniques. Further, the program shed light on existing deficiencies within the health care system. Notably, it revealed that selective laser trabeculoplasty has been underutilized due to limited exposure and a lack of equipment. The Cure Glaucoma Foundation is collaborating with Dr. Swamy to return to Bali and introduce the procedure. Another observation I made in Bali is a need to discuss ways to improve postoperative management of trabeculectomy. To address this, I plan to host an observership at my practice in Dallas for a glaucoma specialist from Udayana University. This will allow the physician to observe postoperative treatment plans for patients over the course of weeks and months, and they will then return to Udayana University to share this knowledge with others.A total of 25 MIGS surgeries were performed, and 36 physicians and medical staff personnel were trained.Access to Care - The purpose of the Access to Care Project (ACP) is to take a proactive approach to reduce the burden of blindness. ACP is designed to address the unmet needs of persons affected by glaucoma with limited financial resources. Patient care provided will include eye exams, surgical, and postoperative clinical care necessary to prevent disease progression and blindness.South Dallas Glaucoma Services Clinic 2023The 2019 Dallas County Needs Assessment highlighted significant health and access disparities, particularly evident in Zip codes 75210, 75216, 75217, and 75241. These areas, predominantly inhabited by Black and Hispanic residents, face heightened vulnerability to glaucoma, the leading cause of blindness among African Americans. Alarmingly, half of those affected are unaware of their condition. Furthermore, glaucoma manifests more aggressively, earlier, and with greater severity in African American populations, posing a significant public health challenge.It has long been the dream of our physician founders, from Glaucoma Associates of Texas (GAT), to extend their reach to the South Dallas community, offering essential glaucoma care. This collaborative program is distinctive in its provision of low-cost glaucoma services to disadvantaged individuals in the Dallas-Fort Worth metroplex, filling a crucial gap that no other nonprofit currently addresses.Our South Dallas Glaucoma Services Clinic serves as a specialized referral center for glaucoma patients identified by organizations like the Center for Vision Health. Patients, regardless of financial status, receive treatment from leading glaucoma specialists, preventing vision loss and disability through access to care and education.In 2023, CGF collaborated with the Society of St. Vincent de Paul Pharmacy of North Texas, providing them with a $7,000 grant to expand their formulary with glaucoma medications. This initiative aims to provide affordable access to essential medications for patients at the South Dallas clinic, fostering medication adherence and ensuring comprehensive care for underserved individuals.In 2023 our South Dallas Glaucoma Services Clinic served 65 patients. FORM 990, PART VI SECTION B, LINE 11B: LINE 11B EXPLANATION - A COPY OF THE FORM 990 WAS PROVIDED TO THE EXECUTIVE DIRECTOR PRIOR TO FILING FOR HIS AND/OR THE BOARD'S REVIEW. UPON APPROVAL THE FORM WILL BE FILED.